ArticleScientific reports2026
Cytotoxic and apoptotic effects of kaempferol 3-O-rhamnoside from Schima wallichii in HepG2 cells.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Schima wallichii (DC.) Korth is a medicinal plant with notable pharmacological potential but remains poorly characterized. In this study, the crude extract and solvent fractions from Schima wallichii leaves were evaluated for cytotoxic activity against various human cancer cell lines. Both the total extract and its fractions exhibited dose-dependent inhibitory effects on the proliferation of hepatocellular carcinoma HepG2 cells. From the most active fraction, a major flavonoid was isolated and identified as kaempferol-3-O-rhamnoside. In vitro assays revealed that kaempferol-3-O-rhamnoside effectively suppressed HepG2 cell growth and induced apoptosis by activating caspase-3, modulating cell cycle progression, and enhancing the expression of cleaved caspase-3 protein. Complementary in silico analyses showed that K3OR bound favorably to apoptosis-related targets, including caspase-3, caspase-8, caspase-9, and PARP-1, with strong hydrogen-bonding and π-π interactions at their catalytic sites. Molecular dynamics simulations confirmed the high structural stability of the kaempferol-3-O-rhamnoside-caspase 3 complex throughout a 100-ns trajectory, while density functional theory calculations indicated a moderate HOMO-LUMO energy gap (6.48 eV), semi-soft electronic nature, and a global electrophilicity index (ω = 3.18 eV), consistent with its favorable binding reactivity. These findings suggest that K3OR exerts cytotoxic effects through caspase-mediated apoptotic activation, providing mechanistic insight into its anti-proliferative activity in liver cancer cells.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.